Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating the role of genetics in kidney disease progression

Official title: The Genetic Contribution to Progression of Kidney Disease

Run by Ospedale San Raffaele · NCT06416761 · Data updated 2026-11-12

This study is trying to see how genetics affects the worsening of kidney diseases like acute kidney injury and chronic kidney disease in people, especially those with high blood pressure.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10000 (estimated)
SponsorOspedale San Raffaele
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedMay 19, 2006
Main results expectedMay 19, 2040
Study endsMay 19, 2041
Registry record updatedMay 16, 2024
Trial IDNCT06416761 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with specific renal diseases such as AKI, CKD, or ADPKD.

Probably not a fit

Patients without any diagnosed renal disease or those not meeting the specific inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how genetic factors contribute to the development and progression of various nephropathies, including acute kidney injury (AKI), chronic kidney disease (CKD), and autosomal dominant polycystic kidney disease (ADPKD). It focuses on understanding the impact of genetic polymorphisms on disease severity and progression, particularly in patients with hypertension and other related conditions. The study aims to identify specific genetic markers that may influence kidney health and disease outcomes, providing insights into personalized treatment approaches.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of kidney diseases through personalized medicine based on genetic profiles.

How similar studies have gone: Other studies have shown promising results in understanding the genetic basis of kidney diseases, indicating that this approach is both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

. presence of specific renal disease

Exclusion Criteria:

* to be evaluated in the different sub-protocols

Where it's running

  • IRCCS Ospedale San Raffaele
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.